Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.
AUTOR(ES)
Kleyweg, R P
RESUMO
Since the introduction of plasma exchange as a treatment for Guillain-Barré syndrome (GBS) patients, treatment related fluctuations have been found to occur in about 10% of the patients. These fluctuations are considered additional evidence of the beneficial effect of plasma exchange. In this report the occurrence of such treatment related fluctuations is described in the 147 patients who took part in the Dutch Guillain-Barré trial comparing high dose intravenous immunoglobulin with plasma exchange. Six of 72 patients in the plasma exchange group and eight of 74 in the immunoglobulin group showed such fluctuation. These results support the biological effect of immunoglobulin. More general use of immunoglobulin should await the full analysis of the Dutch GBS trial which is in progress.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1014615Documentos Relacionados
- The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.
- Treatment of the Guillain-Barré syndrome by plasma exchange.
- Improvement in nerve condition after plasma exchange for Guillain-Barré syndrome.
- Treatment-related fluctuations in Guillain-Barré syndrome: clinical features and predictors of recurrence
- Plasma infusion in childhood Guillain-Barré syndrome.
